Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan

Clinical trial NCT00258908 · COMPLETED

Trial details

NCT number: NCT00258908
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis

Start date: 2005-11-01
Primary completion: 2006-08-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.